Senior insider sale
HALOZYME THERAPEUTICS, INC. — senior position signals high conviction
$399.9K
4.88K shares
What this filing means
CONNAUGHTON BERNADETTE plans to sell 4.88K shares of HALOZYME THERAPEUTICS, INC. valued at approximately $399.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/10/2026ACC: 0001950047-26-007890
Director
Since Sep 2018
4.88K
Shares to sell
$399.9K
Approx. market value
1.63K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
4/25/2025
1.63KTotal acquired1.63K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/25/2025 | Restricted Stock Units N/A | 1.63K | — |
| Total | 1.63K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
1.63K
Market value
$124.7K
7/1/2026
—Completed
Units to sell
1.63K
Market value
$107.6K
6/1/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.63K
Market value
$167.7K
8/10/2026
Total
Units
4.88K
Value
$399.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/1/2026 | 1.63K | $124.7K | — | Completed |
6/1/2026 | 1.63K | $107.6K | — | Completed |
| Planned — Approximate Date | ||||
8/10/2026 | 1.63K | $167.7K | NASDAQ | Planned |
| Total | 4.88K | $399.9K | ||